Nigeria and Brazil Sign Strategic MoU to Boost Local Pharmaceutical Manufacturing and Industrial Cooperation
In a landmark move to strengthen Nigeria’s healthcare and industrial capacity, the Federal Ministry of Health and Social Welfare today hosted the signing of a Memorandum of Understanding (MoU) between the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), EMS Brazil, and Oaks Medical Limited. The ceremony was presided over by the Coordinating Minister of Health and Social Welfare, highlighting the government’s commitment to transforming high-level diplomatic agreements into tangible operational partnerships.
The MoU builds on engagements between President Bola Ahmed Tinubu and Brazilian President Luiz Inácio Lula da Silva during President Tinubu’s recent visit to Brazil. Both leaders underscored the importance of expanding collaboration in pharmaceutical development, vaccine production, and broader industrial growth. The agreement is expected to significantly enhance Nigeria’s capacity for local production of essential medicines and vaccines, reducing dependency on imports and strengthening the country’s health security.
Under this partnership, the Nigeria Health Sector Renewal Investment Initiative (NHSRII) will serve as a framework to systematically unlock bottlenecks in the healthcare value chain. The initiative focuses on technology transfer, capacity building, and scaling up local manufacturing to position Nigeria as a regional hub for pharmaceutical production. By engaging both public and private sector actors, the policy aims to foster sustainable industrial growth and ensure that government-led reforms translate into practical benefits for citizens.
The collaboration is also designed to create long-term technical and industrial linkages between Nigeria and Brazil, promoting knowledge sharing, skills development, and investment in local infrastructure. Through the PVAC platform, the government is working to accelerate vaccine and pharmaceutical self-reliance while generating new economic opportunities, boosting employment, and reinforcing Nigeria’s position in the global healthcare and industrial landscape.
